Foamix Pharma Ord
(FOMX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 443 | 3,595 | 3,669 | 5,527 | 849 |
| Cost of Goods | N/A | N/A | 13 | 59 | 70 |
| Gross Profit | 443 | 3,595 | 3,656 | 5,468 | 779 |
| Operating Expenses | 96,316 | 78,487 | 69,283 | 35,177 | 17,779 |
| Operating Income | -95,873 | -74,892 | -65,614 | -29,650 | -16,930 |
| Other Income | 519 | 941 | 1,063 | 701 | 452 |
| Pre-tax Income | -95,354 | -73,951 | -64,551 | -28,949 | -16,478 |
| Income Tax | -176 | 212 | 1,164 | 387 | 39 |
| Net Income Continuous | -95,178 | -74,163 | -65,715 | -29,336 | -16,517 |
| Net Income | $-95,178 | $-74,163 | $-65,715 | $-29,336 | $-16,517 |
| EPS Basic Total Ops | -1.66 | -1.70 | -1.76 | -0.91 | -0.58 |
| EPS Basic Continuous Ops | -1.66 | -1.70 | -1.76 | -0.91 | -0.59 |
| EPS Diluted Total Ops | -1.66 | -1.70 | -1.76 | -0.91 | -0.58 |
| EPS Diluted Continuous Ops | -1.66 | -1.70 | -1.76 | -0.91 | -0.59 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.70 | -1.76 | -0.91 | -0.58 |
| EBITDA(a) | $-95,523 | $-74,573 | $-65,393 | $-29,507 | $-16,843 |